Clinical Trial

Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine

Name: Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine — clinical trial record (NCT07416110)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate immunogenicity consistency between three consecutive batches of commercial-scale productions for Sinovac Rabies vaccine

Trial Details

NCT Number	NCT07416110
Lead Sponsor	Sinovac Biotech Co., Ltd
Conditions	Rabies (Healthy Volunteers)
Enrollment	912 participants
Start Date	2026-03-04
Primary Completion	2026-09-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-17